Search

everythinglearnresearchcommunity

for

Search:↓

A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.

Early identification of lupus through skin signs and blood tests is crucial in India.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

SLE can occur in young males and cause knee pain.

Laser hair removal is safe for people with Systemic Lupus Erythematosus.

Hair chemicals don't cause SLE but may increase skin issues in those with SLE.

SLE and DM can coexist but are rare and need careful evaluation.

A woman in Sri Lanka was diagnosed with lupus after presenting with protein loss from the gut and other symptoms.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Dermoscopy helped diagnose discoid lupus erythematosus in two patients without needing skin biopsies.